MedPath

se of soft laser for increasing success of inferior alveolar nerve block in symptomatic pulpitis.

Phase 3
Completed
Conditions
Health Condition 1: K040- Pulpitis
Registration Number
CTRI/2023/12/060840
Lead Sponsor
DR SHAHNAZ
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
172
Inclusion Criteria

Healthy patients having a first or second mandibular molar tooth with symptomatic irreversible pulpitis and normal periapical radiographic appearance. The clinical diagnosis of symptomatic irreversible pulpitis will be confirmed by a response to an electric pulp and a prolonged exaggerated response (10 seconds) with moderate to severe pain to a cold test. One hundred twenty patients eligible to participate study will be included.

Exclusion Criteria

Presence of systemic disorders, a sensitivity to lidocaine with 1:80,000 epinephrine or to NSAIDs, nasal polyp, a history of gastrointestinal ulcers, lactation, pregnancy, using any type of analgesic medication in the preceding 12 hours before the treatment, having a tooth not suitable for restoration, and having a full crown.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
success of inferior alveolar nerve block by using Heft parker pain rating scale during root canal treatmentTimepoint: success of inferior alveolar nerve block by using Heft parker pain rating scale during root canal treatment
Secondary Outcome Measures
NameTimeMethod
post endodontic pain following root canal treatment.Timepoint: post operatively after 6, 12, 24 and 48 hrs after treatment
© Copyright 2025. All Rights Reserved by MedPath